Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET
- 24 Juillet 2024 - 1 mn de lecture
The purpose of the study is to evaluate the efficacy and tolerability of the combination of Lanreotide Autogel 120 mg and Temozolomide in patients with progressive gastro-entero-pancreatic neuroendocrine tumours (GEP-NET) graded as G1 or G2 (G1/G2). All progressive tumours classified according to Response Evaluation Criteria In Solid Tumours (RECIST, 1.1).
24 Juillet 2024
1 mn de lecture
A study to evaluate the effect of phenytoin or itraconazole on the circulating levels of IPN60130 in healthy adult participants
24 Juillet 2024
1 mn de lecture
A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ?14 Years With Fibrodysplasia Ossificans Progressiva...
24 Juillet 2024
1 mn de lecture
A study to assess whether adding maintenance cabozantinib (XL184) to best supportive care helps children, adolescents and young adults with osteosarcoma.
24 Juillet 2024
2 mn de lecture
A study to evaluate the effectiveness and safety of Dysport® for the prevention of episodic migraine in adults
24 Juillet 2024
2 mn de lecture
A study to evaluate the effectiveness and safety of Dysport® for the prevention of chronic migraine in adults
24 Juillet 2024
1 mn de lecture
A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity.
24 Juillet 2024
2 mn de lecture
A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours
24 Juillet 2024
2 mn de lecture
Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg vs. Placebo in Subjects With Lung Neuroendocrine Tumours
24 Juillet 2024
1 mn de lecture
Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia
24 Juillet 2024
1 mn de lecture